CTOs on the Move

Nephron Pharmaceuticals

www.nephronpharm.com

 
Nephron Pharmaceuticals Corporation is a mid-sized company that manufactures generic respiratory medications. NPC sells to many classes of trade, including, but not limited to, hospitals, pharmacies, long term care facilities, home care companies and mail order pharmacies. These medications are used in the treatment of asthma and COPD.
  • Number of Employees: 250-1000
  • Annual Revenue: $100-250 Million

Executives

Name Title Contact Details

Similar Companies

MMR Information Systems

MMRGlobal, Inc., formerly known as MMR Information Systems, Inc., provides secure, easy-to-use multilingual Personal Health Records (PHRs) and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, professional organizations and affinity groups.

Physician Billing Service Bureau

Physician Billing Service Bureau is a Dearborn Heights, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Imperial Clinical Research Services

Imperial Clinical Research Services is a Grand Rapids, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Fox Hill Village

Fox Hill Village is a retirement community located in Westwood, Massachusetts that offers independent senior living, assisted living, rehabilitation, and memory care options. The community features 340 resident-owned apartments surrounding a village co...

RainTree Oncology Services

As the nation’s leading community oncology alliance, RainTree Oncology Services assists our member practices in achieving better and more cost effective treatment of oncology patients while creating new streams of revenue for community oncology practices through. Creating a unique aggregated data compilation and analytic platform allowing RainTree members to develop and evaluate care pathways to improve patient care and outcomes while reducing costs to the health care system; and Developing commercial relationships accelerating innovative oncology treatments and payer arrangements while optimizing oncology patient care and advancing the science of oncology.